MedAvante: WIRB-Copernicus Group acquires MedAvante and ProPhase
WIRB-Copernicus Group (WCG), provider of solutions to improve the quality and efficiency of clinical research, has acquired MedAvante and ProPhase, and has named Jeffrey Litwin as the CEO of the combined organisation.
Read full article »
MedAvante provides psychiatric and neurocognition rating and monitoring services for pharmaceutical and medical device sectors.
Read more